Asia Pacific Antibody Discovery Market Size is USD 2.21 Billion by 2026

Asia Pacific Antibody Discovery Market (By Methods: Phage Display, Hybridoma, Others; By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody; By End Users: Pharmaceutical and Biotechnology industry, Research laboratory, Academic laboratory) Industry Size, Share, Growth, Trends 2026 to 2035.

Report Code : 1537 | Published : 04 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 2 Bn

Forecast Year,

USD 5.38 Bn

CAGR, 2026 - 2035

10.40%

Report Coverage

Asia Pacific

Download Databook

The Asia Pacific antibody discovery market size was evaluated at USD 2 billion in 2025 and is predicted to reach around USD 5.38 billion by 2035, expanding at a CAGR of 10.40% from 2026 to 2035. Growing due to rapid expansion of biotech startups and cost-effective clinical research capabilities..

Asia Pacific Antibody Discovery Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 2 Billion
Market Size in 2026	USD 2.21 Billion
Market Size by 2035	USD 5.38 Billion
CAGR 2026 to 2035	10.40%
Base Year	2025
Forecast Period	2026 to 2035

Antibody discovery services are increasingly being outsourced in the area because of cost benefits and the availability of skilled labor. Research and development capabilities are also being improved by growing investments in biotechnology infrastructure.

The market is driven by the growing biotechnology industry and a rise in the outsourcing of discovery services to nations with lower costs. Additionally, the market is expanding more quickly due to increased investments in R&D and better regulatory frameworks.

Segments	Shares (%)
Phage Display	44%
Hybridoma	34%
Others	20%

Phage Display - Phage display segment is dominating with a share of 44% driven by the adoption of advanced technologies. Moreover, increasing outsourcing activities are boosting demand.
Hybridoma - Hybridoma segment is notable with a share of 34% driven by widespread traditional usage. Additionally, cost-effectiveness supports continued utilization.

Segments	Shares (%)
Human Antibody	36%
Humanized Antibody	32%
Chimeric Antibody	18%
Murine Antibody	14%

Humanized Antibody - Humanized antibody segment is notable with a share of 32% driven by improved therapeutic outcomes. In addition, growing healthcare awareness is contributing to demand.
Human Antibody - Human antibody segment is dominating with a share of 36% driven by rising demand for fully human biologics. Furthermore, increasing clinical trials are supporting growth.
Chimeric Antibody - Chimeric antibody segment holds a share of 18% driven by ongoing clinical usage. Moreover, its accessibility supports broader adoption.
Murine Antibody - Murine antibody segment holds a share of 14% driven by preclinical research demand. Additionally, it remains relevant in laboratory studies.

Segments	Shares (%)
Pharmaceutical and Biotechnology Industry	52%
Research Laboratory	28%
Academic Laboratory	20%

Pharmaceutical and Biotechnology Industry - Pharmaceutical and biotechnology industry segment is dominating with a share of 52% driven by expansion in the biotech sector.
Research Laboratory - Research laboratory is notable with a share of 28% driven by increasing experimental research. In addition, supportive policies are enhancing research activities.
Academic Laboratory - Academic laboratory segment holds a share of 20% driven by growing academic initiatives. Moreover, rising student research programs are contributing to demand.

Top Companies in the Asia Pacific Antibody Discovery Market

Danaher Corporation
Eurofins Scientific
Evotec
Twist Bioscience
Charles River Laboratories
Genscript Technology Corporation
Biocytogen
Sartorius AG
Fairjourney Biologics S.A
Creative Biolabs

Segments Covered in the Report

By Methods

Phage Display
Hybridoma
Others

By Antibody Type

Humanized Antibody
Human Antibody
Chimeric Antibody
Murine Antibody

By End Users

Pharmaceutical and Biotechnology industry
Research laboratory
Academic laboratory

List of Tables & Figures

List of Tables

Table 1: Asia Pacific Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 2: Asia Pacific Antibody Discovery Market Size, by Methods, 2025-2035 (USD Billion)
Table 3: Asia Pacific Antibody Discovery Market Size, by Antibody Type, 2025-2035 (USD Billion)
Table 4: Asia Pacific Antibody Discovery Market Size, by End Users, 2025-2035 (USD Billion)
Table 5: Asia Pacific Antibody Discovery Market Size, by Phage Display, 2025-2035 (USD Billion)
Table 6: Asia Pacific Antibody Discovery Market Size, by Hybridoma, 2025-2035 (USD Billion)
Table 7: Asia Pacific Antibody Discovery Market Size, by Others Methods, 2025-2035 (USD Billion)
Table 8: Asia Pacific Antibody Discovery Market Size, by Humanized Antibody, 2025-2035 (USD Billion)
Table 9: Asia Pacific Antibody Discovery Market Size, by Human Antibody, 2025-2035 (USD Billion)
Table 10: Asia Pacific Antibody Discovery Market Size, by Chimeric Antibody, 2025-2035 (USD Billion)
Table 11: Asia Pacific Antibody Discovery Market Size, by Murine Antibody, 2025-2035 (USD Billion)
Table 12: Asia Pacific Antibody Discovery Market Size, by Pharmaceutical and Biotechnology Industry, 2025-2035 (USD Billion)
Table 13: Asia Pacific Antibody Discovery Market Size, by Research Laboratory, 2025-2035 (USD Billion)
Table 14: Asia Pacific Antibody Discovery Market Size, by Academic Laboratory, 2025-2035 (USD Billion)
Table 15: China Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 16: Japan Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 17: South Korea Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 18: India Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 19: Southeast Asia Antibody Discovery Market Size, 2025-2035 (USD Billion)
Table 20: Asia Pacific Antibody Discovery Market Share, by Country, 2025 (%)
Table 21: Asia Pacific Antibody Discovery Market Growth Forecast, 2025-2035 (USD Billion)

List of Figures

Figure 1: Asia Pacific Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 2: Asia Pacific Antibody Discovery Market Share, by Methods, 2025 (%)
Figure 3: Asia Pacific Antibody Discovery Market Share, by Antibody Type, 2025 (%)
Figure 4: Asia Pacific Antibody Discovery Market Share, by End Users, 2025 (%)
Figure 5: Asia Pacific Antibody Discovery Market Share, by Country, 2025 (%)
Figure 6: China Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 7: Japan Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 8: South Korea Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 9: India Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 10: Southeast Asia Antibody Discovery Market Forecast, 2025-2035 (USD Billion)
Figure 11: Phage Display Segment Market Forecast, 2025-2035 (USD Billion)
Figure 12: Hybridoma Segment Market Forecast, 2025-2035 (USD Billion)
Figure 13: Humanized Antibody Segment Market Forecast, 2025-2035 (USD Billion)
Figure 14: Pharmaceutical and Biotechnology Industry Segment Market Forecast, 2025-2035 (USD Billion)
Figure 15: Asia Pacific Antibody Discovery Market Growth Opportunity Map, 2025-2035 (% CAGR)
Figure 16: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Country, 2025 (%)

Research Methodology

Related Databooks

March 2026